Kenneth Kovach, MD
Nephrology · Wichita, KSNPI 1881691186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $516, more than ten times the $29 reported in 2019.
Across 66 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$225
- Travere Therapeutics, Inc.$187
- Vifor Pharma, Inc.$138
- GSK$128
- Mallinckrodt Hospital Products Inc.$118
- AstraZeneca$75
- plus $479 from 15 others
What the payments were for
- Food & beverage$1,347100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $225 |
| Travere Therapeutics, Inc. | 8 | $187 |
| Vifor Pharma, Inc. | 6 | $138 |
| GSK | 7 | $128 |
| Mallinckrodt Hospital Products Inc. | 6 | $118 |
| AstraZeneca | 4 | $75 |
| Novartis | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Boehringer Ingelheim | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| Recor Medical Inc | 1 | $29 |
| Abbott | 2 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Nxstage Medical, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Cormedix Inc. | 1 | $14 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$1,350 in reported general payments places this provider in the 55th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 21 | $48,797 |
| Lanthanum Carbonate | 16 | $15,500 |
| Sevelamer Carbonate | 73 | $14,127 |
| Potassium Citrate ErPotassium Citrate | 13 | $2,066 |
| Midodrine Hcl | 21 | $1,284 |
| Calcium Acetate | 14 | $861 |
| Potassium Chloride | 21 | $720 |
| Colchicine | 20 | $494 |
| Tamsulosin Hcl | 46 | $481 |
| Nifedipine ErNifedipine | 19 | $396 |
| Furosemide | 53 | $334 |
| Finasteride | 19 | $320 |
| Carvedilol | 36 | $305 |
| Prednisone | 49 | $298 |
| Ezetimibe | 16 | $294 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Wichita
- Edgard WehbeWichita$49K
- Dennis RossWichita$12K
- Mohamad SandidWichita$6K
- Jany MoussaWichita$4K
- Amanda ValliantWichita$3K
- Ushasri ChallaWichita$3K
- Joseph MeouchyWichita$2K
- Michael GrantWichita$2K
- Lisa WeberWichita$2K
- Levi ShortWichita$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.